Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 91 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8133898

    Renin inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  2. US 8129381

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  3. US 8129387

    Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  4. US 8129399

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  5. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  6. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  7. US 8124651

    Palmarumycin based inhibitors of thioredoxin and methods of using same

    THE ARIZONA BOARD OF REGENTS · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  8. US 8119649

    Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  9. US 8119631

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  10. US 8119660

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  11. US 8119655

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  12. US 8119656

    Inhibitors of the influenza virus non-structural 1 protein

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  13. US 8115011

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  14. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  15. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  16. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  17. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  18. US 8093382

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  19. US 8093236

    Weekly administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  20. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  21. US 8093392

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  22. US 8093291

    Methods of using and compositions comprising tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  23. US 8088774

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Northwestern University · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  24. US 8088760

    Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted